Literature DB >> 10959687

Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy.

P Aukrust1, S Bjørnsen, B Lunden, K Otterdal, E C Ng, W Ameln, T Ueland, F Müller, N O Solum, F Brosstad, S S Frøland.   

Abstract

Levels of circulating von Willebrand factor (vWf) antigen are thought to reflect endothelial involvement in various disorders. In the present study we found markedly elevated plasma levels of vWf in HIV-infected patients demonstrated on both cross-sectional and longitudinal testing. Notably, we found that a persistent rise in vWf antigen was associated with progression of HIV-related disease. This elevation of vWf antigen represented functionally normal vWf as evaluated by plasma FVIII, ristocetin cofactor assay and vWf multimer analyses. While HIV-infected patients showed enhanced platelet activation, platelets did not contribute substantially to the increased vWf levels. The high vWf levels were significantly correlated with high viral load, and during HAART, the pronounced decline in HIV RNA levels was accompanied by a corresponding decrease in vWf. The persistent elevation of functionally normal vWf during HIV infection, most probably reflecting a persistent endothelial cell activation, may have an important role in the pathogenesis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959687

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

Review 1.  Endothelial dysfunction in HIV infection.

Authors:  Bruno R Cotter
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

2.  Coagulation and morbidity in treated HIV infection.

Authors:  Nicholas T Funderburg; Michael M Lederman
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 3.  Interactions of viruses and the humoral innate immune response.

Authors:  Bailey E Maloney; Krishani Dinali Perera; Danielle R D Saunders; Naemi Shadipeni; Sherry D Fleming
Journal:  Clin Immunol       Date:  2020-02-04       Impact factor: 3.969

4.  SOLUBLE CD40 LIGAND IN DEMENTIA.

Authors:  B Giunta; K P Figueroa; T Town; J Tan
Journal:  Drugs Future       Date:  2009-04-01       Impact factor: 0.148

Review 5.  The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.

Authors:  Jason V Baker; W Keith Henry; James D Neaton
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

Review 6.  Changing patterns in the neuropathogenesis of HIV during the HAART era.

Authors:  T D Langford; S L Letendre; G J Larrea; E Masliah
Journal:  Brain Pathol       Date:  2003-04       Impact factor: 6.508

7.  Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Authors:  Eleanor S Roberts; Michelle A Zandonatti; Debbie D Watry; Lisa J Madden; Steven J Henriksen; Michael A Taffe; Howard S Fox
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

8.  Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy.

Authors:  Emmanouil Papasavvas; Livio Azzoni; Maxwell Pistilli; Aidan Hancock; Griffin Reynolds; Cecile Gallo; Joe Ondercin; Jay R Kostman; Karam Mounzer; Jane Shull; Luis J Montaner
Journal:  AIDS       Date:  2008-06-19       Impact factor: 4.177

Review 9.  Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients.

Authors:  Nicholas T Funderburg
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

10.  The Relationship Between HIV Infection and Cardiovascular Disease.

Authors:  Birgitt Dau; Mark Holodniy
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.